Clinical trial
Study of Thymopentin in Patients After Curative Resection of Small…
NCT00460681 · Fudan University, Other · Unknown status
Key facts
| NCT number | NCT00460681 |
|---|---|
| Title | Study of Thymopentin in Patients After Curative Resection of Small Hepatocellular Carcinoma |
| Official title | Phase III Study of Thymopentin in Patients After Curative Resection of Small |
| Lead sponsor | Fudan University, Other |
| Status | Unknown status |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Hepatocellular Carcinoma |
| Intervention type | Drug |
| Interventions | Thymopentin |
| Enrollment | 220 |
| Start date | Feb 1, 2007 |
| Completion | Feb 1, 2012 |
| First posted | Apr 16, 2007 |
| Last update posted | Oct 31, 2007 |
| Countries | China |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: